A group of end-payor plaintiffs filed a request for preliminary approval of the proposed settlement Oct. 24 in the US District Court for the District of Massachusetts.
The settlement comes more than two years after a group of health and welfare funds of labor unions sued Teva, alleging it prolonged a monopoly over its brand name “QVAR” line of asthma inhalers by paying Amneal Pharmaceuticals to delay the generic version of the product. Teva acquired the rights to QVAR ...